BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37210410)

  • 21. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
    Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
    J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.
    Ahn JC; Lauzon M; Luu M; Noureddin M; Ayoub W; Kuo A; Sundaram V; Kosari K; Nissen N; Gong J; Hendifar A; Roberts LR; Abou-Alfa GK; Singal AG; Yang JD
    Hepatology; 2022 Dec; 76(6):1649-1659. PubMed ID: 35429171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of Care and Survival in Stage III NSCLC Among Black and Latino Patients Compared With White Patients.
    Vyfhuis MAL; Bentzen SM; Molitoris JK; Diwanji T; Badiyan S; Grover S; Adebamowo CA; Simone CB; Mohindra P
    Clin Lung Cancer; 2019 Jul; 20(4):248-257.e4. PubMed ID: 30910573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Race and sex differences in the receipt of timely and appropriate lung cancer treatment.
    Shugarman LR; Mack K; Sorbero ME; Tian H; Jain AK; Ashwood JS; Asch SM
    Med Care; 2009 Jul; 47(7):774-81. PubMed ID: 19536007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area.
    Hua X; Ward KC; Gillespie TW; Lipscomb J; Goodman M
    J Community Health; 2014 Aug; 39(4):696-705. PubMed ID: 24346819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
    Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
    Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients.
    Palazzo LL; Sheehan DF; Tramontano AC; Kong CY
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):926-934. PubMed ID: 30787053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007-2016.
    Shah M; Parmar A; Chan KKW
    Cancer Med; 2020 May; 9(10):3407-3416. PubMed ID: 32196964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial and Socioeconomic Disparities After Carotid Procedures.
    Vogel TR; Kruse RL; Kim RJ; Dombrovskiy VY
    Vasc Endovascular Surg; 2018 Jul; 52(5):330-334. PubMed ID: 29554858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States.
    Nathan AS; Geng Z; Dayoub EJ; Khatana SAM; Eberly LA; Kobayashi T; Pugliese SC; Adusumalli S; Giri J; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e005600. PubMed ID: 30950652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.
    Guadamuz JS; Ozenberger K; Qato DM; Ko NY; Saffore CD; Adimadhyam S; Cha AS; Moran KM; Sweiss K; Patel PR; Chiu BC; Calip GS
    Medicine (Baltimore); 2019 Nov; 98(46):e17960. PubMed ID: 31725657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial Disparities in Resection of Early Stage Non-Small Cell Lung Cancer: Variability Among Surgeons.
    Ezer N; Mhango G; Bagiella E; Goodman E; Flores R; Wisnivesky JP
    Med Care; 2020 Apr; 58(4):392-398. PubMed ID: 31895307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Care Access Measures and Palliative Care Use by Race/Ethnicity among Metastatic Gynecological Cancer Patients in the United States.
    Islam JY; Saraiya V; Previs RA; Akinyemiju T
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34199732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US.
    Moyers JT; Patel A; Shih W; Nagaraj G
    JAMA Netw Open; 2020 Sep; 3(9):e2015656. PubMed ID: 32876684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study.
    Willén L; Berglund A; Bergström S; Bergqvist M; Öjdahl-Bodén A; Wagenius G; Lambe M
    Lung Cancer; 2019 May; 131():40-46. PubMed ID: 31027696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparities in Tumor Mutational Burden, Immunotherapy Use, and Outcomes Based on Genomic Ancestry in Non-Small-Cell Lung Cancer.
    Brawley OW; Luhn P; Reese-White D; Ogbu UC; Madhavan S; Wilson G; Cox M; Ewing A; Hammer C; Richie N
    JCO Glob Oncol; 2021 Sep; 7():1537-1546. PubMed ID: 34752134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic.
    Eberly LA; Kallan MJ; Julien HM; Haynes N; Khatana SAM; Nathan AS; Snider C; Chokshi NP; Eneanya ND; Takvorian SU; Anastos-Wallen R; Chaiyachati K; Ambrose M; O'Quinn R; Seigerman M; Goldberg LR; Leri D; Choi K; Gitelman Y; Kolansky DM; Cappola TP; Ferrari VA; Hanson CW; Deleener ME; Adusumalli S
    JAMA Netw Open; 2020 Dec; 3(12):e2031640. PubMed ID: 33372974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
    Zhu J; Fedewa S; Chen AY
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.